TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
about
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progressionPrevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohortExome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerThe role of SPINK1 in ETS rearrangement-negative prostate cancersCharacterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancerDiagnosis of prostate cancer via nanotechnological approachRecurrent rearrangements in prostate cancer: causes and therapeutic potentialDiscovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate TissueFISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome.Role of the TMPRSS2-ERG gene fusion in prostate cancerEvaluation and prognostic significance of ACAT1 as a marker of prostate cancer progressionThe mutational landscape of lethal castration-resistant prostate cancerIntegrative genomic profiling of human prostate cancerPrognostic outlier genes for enhanced prostate cancer treatment.Chromosomal structural variations during progression of a prostate epithelial cell line to a malignant metastatic state inactivate the NF2, NIPSNAP1, UGT2B17, and LPIN2 genesMolecular characterization of TMPRSS2-ERG gene fusion in the NCI-H660 prostate cancer cell line: a new perspective for an old model.Unraveling the clonal hierarchy of somatic genomic aberrations.ERG induces taxane resistance in castration-resistant prostate cancerERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal originAndrogen regulation of the androgen receptor coregulators.Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer.TMPRSS2:ERG gene fusion variants induce TGF-β signaling and epithelial to mesenchymal transition in human prostate cancer cellsMicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer.Differential gene expression in benign prostate epithelium of men with and without prostate cancer: evidence for a prostate cancer field effect.SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancerOverexpression of full-length ETV1 transcripts in clinical prostate cancer due to gene translocation.Evaluation of ERG responsive proteome in prostate cancerUnique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.Recurrent prostate cancer genomic alterations predict response to brachytherapy treatmentThe role of TMPRSS2:ERG in molecular stratification of PCa and its association with tumor aggressiveness: a study in Brazilian patients.Redefining hormone resistance in prostate cancer.Role of TMPRSS2-ERG gene fusion in negative regulation of PSMA expression.New strategies in prostate cancer: translating genomics into the clinicAntibody-based detection of ERG rearrangement-positive prostate cancerThe identification of chromosomal translocation, t(4;6)(q22;q15), in prostate cancerMolecular genetics of prostate cancer: new prospects for old challengesEvidence for molecular differences in prostate cancer between African American and Caucasian menAntibody-independent targeted quantification of TMPRSS2-ERG fusion protein products in prostate cancer.Performance of a single assay for both type III and type VI TMPRSS2:ERG fusions in noninvasive prediction of prostate biopsy outcome.Single-cell genetic analysis reveals insights into clonal development of prostate cancers and indicates loss of PTEN as a marker of poor prognosis.
P2860
Q24313269-561B564F-EA1D-499B-AF00-562B0DC10214Q24606772-10F84AC8-5071-473A-B976-1D59869FEC05Q24616117-E9521024-7A54-41F0-B6BC-14C54B4847B6Q24647020-C8CD9200-B181-433B-B87F-F6053E01FD9DQ24650647-09B53A21-4785-4FE1-96A5-454E4F2C28FBQ26777322-B865428F-343A-4C04-A1F9-1E1547CEAF4AQ26851525-C02529F7-C46F-46EB-81BA-31905C8E6D4BQ26997884-98723E8D-43E2-4190-BC10-8E589C757C8CQ27851411-CE9A56E6-F596-4E14-AB18-16204DCFCEEDQ28269156-96A00258-890D-4746-A99F-201867F920E6Q28303423-1ABC6CCD-3DA6-4748-A569-950CDB54F056Q29614634-A8EFD347-DD5E-4604-B7A8-367AE83708B5Q29619905-1CB844FA-7460-43F5-A317-65ECBF12C25FQ30244674-4BDE3E7A-EBC0-4BED-AE2F-DF2F72350C5EQ30414829-6BE9BB50-4BA8-4D6D-8345-24F0C3DAE64FQ30479181-AF12FD30-E59C-4507-923B-8D3414FD6374Q30587156-5D140A50-0422-4C61-9705-3EE10A163B0EQ30602046-FEBA8D14-E5F6-46FD-95DF-C2BE383A890DQ31005436-00385680-7ECB-491F-96B0-6E6F21DBDC5BQ33357016-45BF7A53-FFD8-403E-BE34-21C79C39FDA4Q33359279-00CACD50-E344-4ACB-A958-F58A07D29D9AQ33648775-7845ED43-6069-4081-9879-D80473C2AC5DQ33665100-448AB660-154F-446F-A340-4C4150D80C03Q33714055-48A8E559-8117-442B-B267-C2A37276373EQ33777675-B6C03852-F1EE-4371-8125-682C0630C5EFQ33813603-98004C64-6160-474A-B98E-EFF17031E149Q33822319-2C2D8D12-16BE-4256-AB51-C5FDECD2C28FQ33833942-AEB7F6A5-C906-4F74-BE8A-8F823BC1EEA3Q33852664-29415930-59BE-4CE3-886E-E5B1A6F16445Q33876961-9B32F642-FE97-4BE0-ADD2-970632A16511Q33903836-2D47DDAD-639F-4450-B31A-47263301CE45Q33952306-E3458EE9-65DE-4876-9A8E-8F02D7C0CD5BQ34007943-054B63B1-FC33-4954-A1EA-4EEF7E9DCCC9Q34009867-C86C9626-E655-462D-9833-DE6E1CC140B7Q34050388-4BE9B1E4-11D0-44FF-A963-CF62127DF62CQ34127462-8003435D-1640-46CB-8D54-57E9E8E29379Q34205227-8FB8B0B7-A8AB-4733-84A7-F0B8A8AF6695Q34283031-4FFA5A30-4787-4C83-AB80-A147340F151FQ34296258-4E32A281-5DCA-44FD-8199-36A34A3C3D0DQ34302881-7B043788-4540-47B3-B096-DEA995ECBC5B
P2860
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
TMPRSS2:ERG fusion-associated ...... erogeneity of prostate cancer.
@en
type
label
TMPRSS2:ERG fusion-associated ...... erogeneity of prostate cancer.
@en
prefLabel
TMPRSS2:ERG fusion-associated ...... erogeneity of prostate cancer.
@en
P2093
P50
P1433
P1476
TMPRSS2:ERG fusion-associated ...... erogeneity of prostate cancer.
@en
P2093
Arul M Chinnaiyan
Charles Lee
Folke H Schmidt
Joelle Tchinda
Juan-Miguel Mosquera
Matthias D Hofer
Rainer Kuefer
Rameen Beroukhim
Robert Vessella
Scott A Tomlins
P304
P356
10.1158/0008-5472.CAN-06-1482
P407
P577
2006-09-01T00:00:00Z